Keywords: roche, valcyte, works, up, days, trial, swiss

Roche's Valcyte works up to 200 days; trial

Article | 23 February 2009

Print This

Swiss drug major Roche met its primary in a Phase III study investigating the efficacy and safety prophylaxis with Valcyte ( ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in